Nurjati Chairani Siregar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Nurjati Chairani Siregar has a total of 55 co-authors. Here are the top co-authors by number of shared publications:
- Achmad Fauzi Kamal
Department of Orthopedic and traumatology, Faculty of Medicine, Universitas Indonesia, Indonesia
2 shared publications Aru Wisaksono Sudoyo
University of Indonesia
2 shared publicationsDemak Lumban Tobing
National Cancer Center, Dharmais Cancer Hospital
2 shared publications- Herqutanto Herqutanto
Universitas Indonesia
2 shared publications - Mohamad Sadikin
Department of Biochemistry and Molecular Biology, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia
2 shared publications Rebecca Noerjani Angka
Program Doktoral Ilmu Biomedik FKUI
2 shared publications
Latest Publications
- Open Access
Protective Effects of 5-MTP in a Rat Model of Diabetic Cardiomyopathy Through Anti-Inflammatory, Anti-Apoptotic, and Antifibrotic Mechanisms
Background: Diabetic cardiomyopathy (DCM) is characterized by myocardial inflammation, apoptosis, and fibrosis that contribute to ventricular remodeling and dysfunction. We investigated the effects of 5-methoxytryptophan (5-MTP) on histopathological and molecular markers of myocardial remodeling in a rat model of DCM. Methods: Forty-eight Sprague–Dawley rats with DCM induced by a high-fat high-fructose diet and low-dose streptozotocin (25 mg/kg) were randomized to control or 5-MTP treatment (25, 50, or 100 mg/kg) and evaluated after 8, 16, and 32 days. Histopathological assessment using hematoxylin–eosin and Masson’s trichrome staining, along with immunohistochemical analysis of inflammatory, apoptotic, and fibrotic markers, was performed. Results: Myocardial inflammatory histopathological scores did not differ significantly among groups. Myocardial fibrosis assessed by Masson’s trichrome staining was significantly reduced at day 16 (p = 0.020), with all 5-MTP doses demonstrating lower fibrosis scores than DCM controls. Collagen I expression did not differ significantly. Caspase-3 expression was significantly reduced in all treatment groups at day 16 (p = 0.029), with persistent reduction at day 32 only in the 100 mg/kg group (p = 0.004). Early molecular modulation was observed through reduced TGF-β expression at day 8 in the 25 mg/kg and 50 mg/kg groups, followed by reduced SMAD3 expression at day 16 in the 25 mg/kg and 100 mg/kg groups. At day 16, AKT expression increased in the 25 mg/kg group, while cytoplasmic NF-κB expression decreased in the 25 mg/kg and 100 mg/kg groups. Conclusion: 5-MTP demonstrated time-dependent changes in molecular and histopathological markers associated with myocardial remodeling in experimental DCM.
Open AccessProtective Effects of 5-MTP in a Rat Model of Diabetic Cardiomyopathy Through Anti-Inflammatory, Anti-Apoptotic, and Antifibrotic Mechanisms
Background: Diabetic cardiomyopathy (DCM) is characterized by myocardial inflammation, apoptosis, and fibrosis that contribute to ventricular remodeling and dysfunction. We investigated the effects of 5-methoxytryptophan (5-MTP) on histopathological and molecular markers of myocardial remodeling in a rat model of DCM. Methods: Forty-eight Sprague–Dawley rats with DCM induced by a high-fat high-fructose diet and low-dose streptozotocin (25 mg/kg) were randomized to control or 5-MTP treatment (25, 50, or 100 mg/kg) and evaluated after 8, 16, and 32 days. Histopathological assessment using hematoxylin–eosin and Masson’s trichrome staining, along with immunohistochemical analysis of inflammatory, apoptotic, and fibrotic markers, was performed. Results: Myocardial inflammatory histopathological scores did not differ significantly among groups. Myocardial fibrosis assessed by Masson’s trichrome staining was significantly reduced at day 16 (p = 0.020), with all 5-MTP doses demonstrating lower fibrosis scores than DCM controls. Collagen I expression did not differ significantly. Caspase-3 expression was significantly reduced in all treatment groups at day 16 (p = 0.029), with persistent reduction at day 32 only in the 100 mg/kg group (p = 0.004). Early molecular modulation was observed through reduced TGF-β expression at day 8 in the 25 mg/kg and 50 mg/kg groups, followed by reduced SMAD3 expression at day 16 in the 25 mg/kg and 100 mg/kg groups. At day 16, AKT expression increased in the 25 mg/kg group, while cytoplasmic NF-κB expression decreased in the 25 mg/kg and 100 mg/kg groups. Conclusion: 5-MTP demonstrated time-dependent changes in molecular and histopathological markers associated with myocardial remodeling in experimental DCM.
- Open Access
- 23 July 2025
- Published by Springer Nature in European Journal of Orthopaedic Surgery & Traumatology
- Vol. 35 (1) , 1-11
Cluster of differentiation 133 (CD133) and C-X-C chemokine receptor 4 (CXCR4) associated with the incidence of metastasis in osteosarcoma patients
Background Osteosarcoma has a global incidence of 3.4 cases per million annually, with 10–20% of patients presenting with metastasis at diagnosis. Its high metastatic potential is attributed to a highly proliferative cell population and cancer stem cells that drive tumorigenesis and metastasis. This study examines the relationship between CD133 and CXCR4 expression and metastasis in osteosarcoma. Methods Using a cross-sectional approach, blood serum from osteosarcoma patients diagnosed at two centers was analyzed for CD133 and CXCR4 levels via Reed Biotech ELISA KIT. Absorbance quantified marker levels, and metastasis data were obtained from medical records. A chi-square test assessed the relationship between marker levels and metastasis, with significance set at p < 0.05. Results Among 40 patients (80% < 40 years), mean CD133 was 0.23 ± 0.02 pg/ml and mean CXCR4 was 6015.82 ± 2345.55 pg/ml. CD133 and CXCR4 levels were significantly associated with metastasis (p = 0.009 and p < 0.001, respectively). Conclusion These findings suggest that higher expression of CD133 and CXCR4 correlates with increased metastasis in osteosarcoma, underscoring their potential roles in predicting metastatic behavior and aiding in targeted therapeutic strategies.
- 23 July 2025
- Published by Springer Nature in European Journal of Orthopaedic Surgery & Traumatology
- Vol. 35 (1) , 1-11
Open AccessCluster of differentiation 133 (CD133) and C-X-C chemokine receptor 4 (CXCR4) associated with the incidence of metastasis in osteosarcoma patients
Background Osteosarcoma has a global incidence of 3.4 cases per million annually, with 10–20% of patients presenting with metastasis at diagnosis. Its high metastatic potential is attributed to a highly proliferative cell population and cancer stem cells that drive tumorigenesis and metastasis. This study examines the relationship between CD133 and CXCR4 expression and metastasis in osteosarcoma. Methods Using a cross-sectional approach, blood serum from osteosarcoma patients diagnosed at two centers was analyzed for CD133 and CXCR4 levels via Reed Biotech ELISA KIT. Absorbance quantified marker levels, and metastasis data were obtained from medical records. A chi-square test assessed the relationship between marker levels and metastasis, with significance set at p < 0.05. Results Among 40 patients (80% < 40 years), mean CD133 was 0.23 ± 0.02 pg/ml and mean CXCR4 was 6015.82 ± 2345.55 pg/ml. CD133 and CXCR4 levels were significantly associated with metastasis (p = 0.009 and p < 0.001, respectively). Conclusion These findings suggest that higher expression of CD133 and CXCR4 correlates with increased metastasis in osteosarcoma, underscoring their potential roles in predicting metastatic behavior and aiding in targeted therapeutic strategies.
- Open Access
Placental Protein 13 and Syncytiotrophoblast Basement Membrane Ultrastructures in Preeclampsia
Background and Objectives: Preeclampsia has been linked to an inflammatory response that may be brought on by endothelial cell dysfunction. This paper investigates the pathomechanism of syncytiotrophoblast basement membrane (STBM) damage and Placental Protein 13 (PP13) release, which may have a role in systemic endothelial dysfunction in preeclampsia. Materials and Methods: This comparative cross-sectional study involves 54 preeclampsia patients (27 early-onset preeclampsia and 27 late-onset preeclampsia) and 27 pregnant women with normal blood pressure. An enzyme-linked immunosorbent assay was performed to evaluate maternal blood levels of PP13. Following birth, a portion of the placenta was collected for transmission electron microscope (TEM) and immunohistochemical (IHC) analysis. The data were analyzed using STATA version 15. Results: PP13 expression in the placental syncytiotrophoblast was significantly lower in the early-onset preeclampsia, compared to late-onset preeclampsia and normotensive pregnancy, group (p < 0.001). In contrast, serum PP13 levels were found to be the highest in the early-onset preeclampsia group, although no significant difference were found in mean maternal serum levels of PP13 between the three groups. The decreased PP13 expression in placental syncytiotrophoblast can be attributed to the greater extent of damage in the STBM in early-onset preeclampsia that leads to the release of a larger amount of PP13 into maternal circulation. The hypothesis aligns with the TEM analysis results. Preeclamptic pregnancies showed placental syncytiotrophoblast aponeurosis, whereas normotensive pregnancies did not. Placental lesions and STBM shedding were found to be more pronounced in early-onset preeclampsia compared to late-onset preeclampsia. Conclusions: PP13 and STBM damage may play a role in systemic endothelial dysfunction in preeclampsia.
Open AccessPlacental Protein 13 and Syncytiotrophoblast Basement Membrane Ultrastructures in Preeclampsia
Background and Objectives: Preeclampsia has been linked to an inflammatory response that may be brought on by endothelial cell dysfunction. This paper investigates the pathomechanism of syncytiotrophoblast basement membrane (STBM) damage and Placental Protein 13 (PP13) release, which may have a role in systemic endothelial dysfunction in preeclampsia. Materials and Methods: This comparative cross-sectional study involves 54 preeclampsia patients (27 early-onset preeclampsia and 27 late-onset preeclampsia) and 27 pregnant women with normal blood pressure. An enzyme-linked immunosorbent assay was performed to evaluate maternal blood levels of PP13. Following birth, a portion of the placenta was collected for transmission electron microscope (TEM) and immunohistochemical (IHC) analysis. The data were analyzed using STATA version 15. Results: PP13 expression in the placental syncytiotrophoblast was significantly lower in the early-onset preeclampsia, compared to late-onset preeclampsia and normotensive pregnancy, group (p < 0.001). In contrast, serum PP13 levels were found to be the highest in the early-onset preeclampsia group, although no significant difference were found in mean maternal serum levels of PP13 between the three groups. The decreased PP13 expression in placental syncytiotrophoblast can be attributed to the greater extent of damage in the STBM in early-onset preeclampsia that leads to the release of a larger amount of PP13 into maternal circulation. The hypothesis aligns with the TEM analysis results. Preeclamptic pregnancies showed placental syncytiotrophoblast aponeurosis, whereas normotensive pregnancies did not. Placental lesions and STBM shedding were found to be more pronounced in early-onset preeclampsia compared to late-onset preeclampsia. Conclusions: PP13 and STBM damage may play a role in systemic endothelial dysfunction in preeclampsia.
- Open Access
- 31 December 2022
- Published by Atma Jaya Catholic University of Indonesia in Damianus Journal of Medicine
- Vol. 21 (3) , 275-283
Biopsi cair pada kanker kolorektal: Harapan dan tantangan
Pendahuluan: Global Cancer Statistics 2020 menunjukkan angka kejadian kanker kolorektal menduduki peringkat ketiga dengan urutan kedua angka kematian. Pemeriksaan biopsi cair pada kanker kolorektal mulai dilakukan untuk mempelajari sel-sel tumor yang ada di dalam sirkulasi yaitu circulating tumor cells (CTCs) dan cell-free circulating tumor DNA (ctDNA/cfDNA). Tujuan dari penulisan artikel ini adalah untuk menemukan dan menelaah penelitian-penelitian yang telah dilakukan mengenai biopsi cair baik dari sisi metode, hasil maupun manfaat klinik pada kanker kolorektal. Metode: Metode pencarian literatur dilakukan melalui Embase, Scopus dan PubMed. Dari 143 artikel yang ditemukan saat pencarian awal, setelah melalui tahap seleksi akhir ditentukan 15 artikel yang memenuhi kriteria inklusi. Hasil: Biopsi cair dapat digunakan untuk mendeteksi mutasi yang tidak ditemukan pada tumor primer pasien kanker kolorektal serta analisis kombinasi circulating cell-free DNA (ccfDNA) dan ctcDNA dapat meningkatkan jumlah mutasi yang terdeteksi. Analisis ctDNA dalam plasma yang dikumpulkan secara serial, memungkinkan mendeteksi ctDNA mutan yang muncul, sehingga dapat digunakan untuk memantau perkembangan penyakit pasien serta menemukan mekanisme resistensi. Pengambilan sampel pasien secara serial menunjukkan bahwa penurunan metilasi terjadi pada pasien yang berespon baik terhadap pengobatan, baik operasi maupun kemoterapi. Sebaliknya pasien yang tidak diobati atau mengalami kekambuhan menunjukkan peningkatan metilasi. Status MSI pada kanker kolorektal yang terdeteksi melalui cfDNA relatif konsisten dengan yang ada di sampel jaringan tumor. Simpulan: Keuntungan biopsi cair adalah darah lebih mudah didapat, efektif dan tidak invasif dibandingkan dengan biopsi terutama pada tumor yang sulit dijangkau dengan biopsi. Biopsi cair dapat dilakukan berulang secara serial sehingga dapat digunakan untuk memantau perkembangan penyakit, mengetahui respon pengobatan dan menentukan prognosis.
- 31 December 2022
- Published by Atma Jaya Catholic University of Indonesia in Damianus Journal of Medicine
- Vol. 21 (3) , 275-283
Open AccessBiopsi cair pada kanker kolorektal: Harapan dan tantangan
Pendahuluan: Global Cancer Statistics 2020 menunjukkan angka kejadian kanker kolorektal menduduki peringkat ketiga dengan urutan kedua angka kematian. Pemeriksaan biopsi cair pada kanker kolorektal mulai dilakukan untuk mempelajari sel-sel tumor yang ada di dalam sirkulasi yaitu circulating tumor cells (CTCs) dan cell-free circulating tumor DNA (ctDNA/cfDNA). Tujuan dari penulisan artikel ini adalah untuk menemukan dan menelaah penelitian-penelitian yang telah dilakukan mengenai biopsi cair baik dari sisi metode, hasil maupun manfaat klinik pada kanker kolorektal. Metode: Metode pencarian literatur dilakukan melalui Embase, Scopus dan PubMed. Dari 143 artikel yang ditemukan saat pencarian awal, setelah melalui tahap seleksi akhir ditentukan 15 artikel yang memenuhi kriteria inklusi. Hasil: Biopsi cair dapat digunakan untuk mendeteksi mutasi yang tidak ditemukan pada tumor primer pasien kanker kolorektal serta analisis kombinasi circulating cell-free DNA (ccfDNA) dan ctcDNA dapat meningkatkan jumlah mutasi yang terdeteksi. Analisis ctDNA dalam plasma yang dikumpulkan secara serial, memungkinkan mendeteksi ctDNA mutan yang muncul, sehingga dapat digunakan untuk memantau perkembangan penyakit pasien serta menemukan mekanisme resistensi. Pengambilan sampel pasien secara serial menunjukkan bahwa penurunan metilasi terjadi pada pasien yang berespon baik terhadap pengobatan, baik operasi maupun kemoterapi. Sebaliknya pasien yang tidak diobati atau mengalami kekambuhan menunjukkan peningkatan metilasi. Status MSI pada kanker kolorektal yang terdeteksi melalui cfDNA relatif konsisten dengan yang ada di sampel jaringan tumor. Simpulan: Keuntungan biopsi cair adalah darah lebih mudah didapat, efektif dan tidak invasif dibandingkan dengan biopsi terutama pada tumor yang sulit dijangkau dengan biopsi. Biopsi cair dapat dilakukan berulang secara serial sehingga dapat digunakan untuk memantau perkembangan penyakit, mengetahui respon pengobatan dan menentukan prognosis.
- Open Access
- 5 December 2022
- Published by DiscoverSys, Inc. in Bali Medical Journal
- Vol. 12 (1) , 255-260
Profile of matrix metalloproteinase activity, markers of collagen and elastin degradation and remodeling during pregnancy, delivery, and puerperium in pelvic organ prolapse 3 months after childbirth
Background: This study aims to assess the condition of pelvic organ prolapse related to changes in matrix metalloproteinase activity, elastin degradation and markers of collagen, and remodeling observed during pregnancy, childbirth, and the puerperal period 3 months postpartum. This study included 39 primigravida women who underwent vaginal delivery with a gestational age >36 weeks. This study conducted laboratory tests using blood and urine samples including procollagen type I N-propeptide (PINP), procollagen type-III N-propeptide (PIIINP), telopeptide carboxyl-terminal collagen type I (ICTP), matrix metalloproteinase-9 (MMP). -9), desmosin, and tropoelastin. The second and third blood samples will be examined 24-48 hours postpartum and 6 weeks postpartum. Method: The Mann-Whitney test and Repeated ANOVA were used to assess the median differences between biomarkers. Results: In the pelvic floor dysfunction and control groups, a significant relationship was found between serum MMP-9 levels 6 weeks postpartum (p=0.025). There were changes in biomarker levels of collagen and elastin during pregnancy, post-partum, and six weeks postpartum. The amount of degradation (MMP-9) seems to be correlated with the event of POP after childbirth. Conclusion: There were changes in the biomarker levels of collagen and elastin from pregnancy, post-partum, and six weeks postpartum. In addition, the difference was significant in MMP-9 level six weeks after postpartum in POP group compare to control.
- 5 December 2022
- Published by DiscoverSys, Inc. in Bali Medical Journal
- Vol. 12 (1) , 255-260
Open AccessProfile of matrix metalloproteinase activity, markers of collagen and elastin degradation and remodeling during pregnancy, delivery, and puerperium in pelvic organ prolapse 3 months after childbirth
Background: This study aims to assess the condition of pelvic organ prolapse related to changes in matrix metalloproteinase activity, elastin degradation and markers of collagen, and remodeling observed during pregnancy, childbirth, and the puerperal period 3 months postpartum. This study included 39 primigravida women who underwent vaginal delivery with a gestational age >36 weeks. This study conducted laboratory tests using blood and urine samples including procollagen type I N-propeptide (PINP), procollagen type-III N-propeptide (PIIINP), telopeptide carboxyl-terminal collagen type I (ICTP), matrix metalloproteinase-9 (MMP). -9), desmosin, and tropoelastin. The second and third blood samples will be examined 24-48 hours postpartum and 6 weeks postpartum. Method: The Mann-Whitney test and Repeated ANOVA were used to assess the median differences between biomarkers. Results: In the pelvic floor dysfunction and control groups, a significant relationship was found between serum MMP-9 levels 6 weeks postpartum (p=0.025). There were changes in biomarker levels of collagen and elastin during pregnancy, post-partum, and six weeks postpartum. The amount of degradation (MMP-9) seems to be correlated with the event of POP after childbirth. Conclusion: There were changes in the biomarker levels of collagen and elastin from pregnancy, post-partum, and six weeks postpartum. In addition, the difference was significant in MMP-9 level six weeks after postpartum in POP group compare to control.
- Open Access
- 2 December 2022
- Published by Galaxy Science
Molecular Aspects of Colorectal Cancer Prognosis in 10 years
Colorectal cancer (CRC) ranks third in the world with an increasing mortality rate, prompting an analysis of various studies that have been conducted over the last 10 years. The inclusion criteria of the analyzed research articles were studies involving the molecular aspects of colorectal cancer associated with its prognosis in the last 10 years. The international literature search method was carried out through article data published in Embase, Scopus, and PubMed using keywords: colorectal cancer, molecular aspects, and prognosis. Through the 440 articles found during the first search out, after going through the final selection stage, 29 articles were determined that met the inclusion criteria. The research method that is widely used in the research analyzed is immunohistochemistry accompanied by PCR. Various molecular aspects have been found to play a role in determining carcinogenesis, response to therapy, and the prognosis of CRC. They generally examine aspects of genes and progress towards microRNA and some molecular aspects are still useful in determining the prognosis so they are still being worked on at this time but further research is needed to further complement the existing data about CRC.
- 2 December 2022
- Published by Galaxy Science
Open AccessMolecular Aspects of Colorectal Cancer Prognosis in 10 years
Colorectal cancer (CRC) ranks third in the world with an increasing mortality rate, prompting an analysis of various studies that have been conducted over the last 10 years. The inclusion criteria of the analyzed research articles were studies involving the molecular aspects of colorectal cancer associated with its prognosis in the last 10 years. The international literature search method was carried out through article data published in Embase, Scopus, and PubMed using keywords: colorectal cancer, molecular aspects, and prognosis. Through the 440 articles found during the first search out, after going through the final selection stage, 29 articles were determined that met the inclusion criteria. The research method that is widely used in the research analyzed is immunohistochemistry accompanied by PCR. Various molecular aspects have been found to play a role in determining carcinogenesis, response to therapy, and the prognosis of CRC. They generally examine aspects of genes and progress towards microRNA and some molecular aspects are still useful in determining the prognosis so they are still being worked on at this time but further research is needed to further complement the existing data about CRC.
- Open Access
- 5 October 2021
- Published by MDPI AG in Preprints.org
Fibropreventive and Antifibrotic Effects of Uncaria gambir on Rats with Pulmonary Fibrosis
Pulmonary fibrosis causes scar tissue formation that disrupts the functioning of the lungs. Uncaria gambir (Hunter) Roxb (hereafter gambir)—a plant native to West Sumatra in Indonesia—contains flavonoid (+)-catechin and has strong antioxidant activity, and it can be used to combat pulmonary fibrosis. This random in vivo experimental study analyzed the antifibrotic effect of gambir on the lungs of rats with bleomycin-induced fibrosis. The subjects were 10 groups of 10-week-old male rats weighing around 200–250 g. All groups were terminated at the end of the seventh week or on day 50. The lungs were cleaned, and tissues were taken to analyze inflammatory cell counts and TGF-β1 levels using bronchoalveolar lavage (BAL) with ELISA; type I collagen and tissue inhibitor of metalloproteinase 1 (TIMP-1) levels using immunohistochemistry (IHC); and activation of NF-κB using ELISA and Western blot assays. The most severe histopathological characteristic based on the modified Ashcroft score was in the bleomycin group (BG), whereas the mildest was in the 262 mg/kg of bodyweight antifibrotic gambir-dosed group (AF G262). The results showed a significant difference in the BAL inflammatory cell count (p = 0.017; p < 0.05). AF G262 differed most from the other antifibrotic groups in terms of the number of inflammatory cells (0.63), TGF-β1 levels (3.80), and NF-κB levels (0.48), followed by the 131 mg/kg of bodyweight antifibrotic gambir-dosed group (AF G131), which also differed most from other antifibrotic groups in terms of NF-κB (0.48), TIMP-1 (11.74), and collagen I (14.50) levels. Western blot analysis showed that the fibropreventive and antifibrotic groups had a specific band size of p65, whereas no specific band binding existed in the control group. This study concluded that the administration of AF G262 could improve fibrosis by lysing the extracellular matrix (ECM) in rat lungs.
- 5 October 2021
- Published by MDPI AG in Preprints.org
Open AccessFibropreventive and Antifibrotic Effects of Uncaria gambir on Rats with Pulmonary Fibrosis
Pulmonary fibrosis causes scar tissue formation that disrupts the functioning of the lungs. Uncaria gambir (Hunter) Roxb (hereafter gambir)—a plant native to West Sumatra in Indonesia—contains flavonoid (+)-catechin and has strong antioxidant activity, and it can be used to combat pulmonary fibrosis. This random in vivo experimental study analyzed the antifibrotic effect of gambir on the lungs of rats with bleomycin-induced fibrosis. The subjects were 10 groups of 10-week-old male rats weighing around 200–250 g. All groups were terminated at the end of the seventh week or on day 50. The lungs were cleaned, and tissues were taken to analyze inflammatory cell counts and TGF-β1 levels using bronchoalveolar lavage (BAL) with ELISA; type I collagen and tissue inhibitor of metalloproteinase 1 (TIMP-1) levels using immunohistochemistry (IHC); and activation of NF-κB using ELISA and Western blot assays. The most severe histopathological characteristic based on the modified Ashcroft score was in the bleomycin group (BG), whereas the mildest was in the 262 mg/kg of bodyweight antifibrotic gambir-dosed group (AF G262). The results showed a significant difference in the BAL inflammatory cell count (p = 0.017; p < 0.05). AF G262 differed most from the other antifibrotic groups in terms of the number of inflammatory cells (0.63), TGF-β1 levels (3.80), and NF-κB levels (0.48), followed by the 131 mg/kg of bodyweight antifibrotic gambir-dosed group (AF G131), which also differed most from other antifibrotic groups in terms of NF-κB (0.48), TIMP-1 (11.74), and collagen I (14.50) levels. Western blot analysis showed that the fibropreventive and antifibrotic groups had a specific band size of p65, whereas no specific band binding existed in the control group. This study concluded that the administration of AF G262 could improve fibrosis by lysing the extracellular matrix (ECM) in rat lungs.
- Open Access
- 10 January 2015
- Published by Sciencedomain International in Journal of Cancer and Tumor International
- Vol. 2 (2) , 59-65
Aggressive Recurrent Giant Cell Tumour of Distal Ulna with Pulmonary Metastasis: A Case Report
Pulmonary metastasis rarely originates from a benign tumour, but may occur from giant-cell tumours of bone (GCT). It occurs most frequently in recurrent cases and may result in poor outcomes. We report a case with pulmonary metastases from huge ulcerated recurrent GCT at distal ulna, from diagnostic to limb salvage surgery procedure. Five months after surgery, unfortunately he passed away due to pulmonary metastases.
- 10 January 2015
- Published by Sciencedomain International in Journal of Cancer and Tumor International
- Vol. 2 (2) , 59-65
Open AccessAggressive Recurrent Giant Cell Tumour of Distal Ulna with Pulmonary Metastasis: A Case Report
Pulmonary metastasis rarely originates from a benign tumour, but may occur from giant-cell tumours of bone (GCT). It occurs most frequently in recurrent cases and may result in poor outcomes. We report a case with pulmonary metastases from huge ulcerated recurrent GCT at distal ulna, from diagnostic to limb salvage surgery procedure. Five months after surgery, unfortunately he passed away due to pulmonary metastases.
- Open Access
- 15 November 2014
- Vol. 28, 129
Transplantation of mesenchymal stem cells, recombinant human BMP-2,and their combination in accelerating the union after osteotomy and increasing, the mechanical strength of extracorporeally irradiated femoral autograft in rat models
Background: Delayed union, nonunion, and mechanical failure is still problems encountered in limb salvage surgery (LSS) using extracorporeal irradiation (ECI). This study aimed to determine whether bone marrow mesenchymal stem cells (MSC) and recombinant human bone morphogenetic protein-2 (rhBMP-2) improve hostgraft union after osteotomy and also increase its mechanical strength.
- 15 November 2014
- Vol. 28, 129
Open AccessTransplantation of mesenchymal stem cells, recombinant human BMP-2,and their combination in accelerating the union after osteotomy and increasing, the mechanical strength of extracorporeally irradiated femoral autograft in rat models
Background: Delayed union, nonunion, and mechanical failure is still problems encountered in limb salvage surgery (LSS) using extracorporeal irradiation (ECI). This study aimed to determine whether bone marrow mesenchymal stem cells (MSC) and recombinant human bone morphogenetic protein-2 (rhBMP-2) improve hostgraft union after osteotomy and also increase its mechanical strength.